WallStreetZenWallStreetZen

NASDAQ: IRMD
Iradimed Corp Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Iradimed earnings were $19.2M for the trailing 12 months ending Dec 31, 2024, with 11.8% growth year over year. The latest IRMD earnings report on Dec 31, 2024 announced Q4 2024 earnings of $5.1M, up 1.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, IRMD reported annual earnings of $19.2M, with 11.9% growth. The next IRMD earnings date is Apr 30, 2025.

IRMD past earnings growth

How has IRMD's earnings growth performed historically?

Company
11.76%
Industry
48.25%
Market
63.03%
IRMD's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
IRMD's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
IRMD's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

IRMD earnings history

Current Revenue
$73.2M
Current Earnings
$19.2M
Current Profit Margin
26.3%
IRMD's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

IRMD Return on Equity

Current Company
23.6%
Current Industry
11.5%
Current Market
34.1%
IRMD's Return on Equity (23.6%)... subscribe to Premium to read more.
High Return on Equity Performance

IRMD undefined

Current Company
20.8%
Current Industry
8%
IRMD is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when IRMD announces earnings.

IRMD undefined

Current Company
27.03%
Current Industry
9%
IRMD has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

IRMD vs Medical Device Stocks

TickerEBITDAEarningsY/Y EarningsEPS
IRMD$25.09M$19.23M+12.33%$1.52
BVS$49.51M-$33.54MN/A-$0.52
AXGN$6.08M-$9.96MN/A-$0.23
SIBN-$23.09M-$30.91MN/A-$0.75
RXST-$23.76M-$27.46MN/A-$0.71
View Top Medical Device Stocks

IRMD earnings dates

Next earnings date
Apr 30, 2025

Iradimed Earnings Reports & History FAQ

What were Iradimed's earnings last quarter?

On IRMD's earnings call on Invalid Date, Iradimed (NASDAQ: IRMD) reported Q4 2024 earnings per share (EPS) of $0.41, up 13.89% year over year. Total IRMD earnings for the quarter were $5.15 million. In the same quarter last year, Iradimed's earnings per share (EPS) was $0.36.

If you're new to stock investing, here's how to buy Iradimed stock.

When does Iradimed report earnings?

The next IRMD earnings call is Invalid Date. Add IRMD to your watchlist to be reminded of Iradimed's next earnings date.

What was IRMD's earnings growth in the past year?

As of Iradimed's earnings date in Invalid Date, Iradimed's earnings has grown 11.76% year over year. This is 36.49 percentage points lower than the US Medical Devices industry earnings growth rate of 48.25%. IRMD earnings in the past year totalled $19.23 million.

Is Iradimed profitable or losing money?

As of the last Iradimed earnings report, Iradimed is currently profitable. Iradimed's net profit (also called net income) for the twelve months ending Dec 31, 2024 was $19.23 million, a 11.87% increase year over year.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.